Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ(2) or IL-18Rα

Mostrar otras versiones (1)

The oncolytic adenovirus (Ad) is currently being advanced as a promising antitumor remedy as it selectively replicates in tumor cells and can transfer and amplify therapeutic genes. Interleukin (IL)-12 induces a potent antitumor effect by promoting natural killer (NK) cell and cytotoxic T cell activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, I-K, Lee, J-S, Zhang, S-N, Park, J, Lee, K-M, Sonn, C H, Yun, C-O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169807/
https://www.ncbi.nlm.nih.gov/pubmed/21451575
http://dx.doi.org/10.1038/gt.2011.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169807/
https://www.ncbi.nlm.nih.gov/pubmed/21451575
http://dx.doi.org/10.1038/gt.2011.37

Ejemplares similares